MedTrace Logo

Evaluation of the Synergistic Effect of Combining a Prebiotic and a Postbiotic on Intestinal Discomfort

NCT07420231 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-05-06

No results posted yet for this study

Summary

This study aims to investigate the beneficial effects of the daily consumption of a synbiotic formulation-combining a prebiotic (Berberine, BBR) and a postbiotic (inactivated Bifidobacterium Longum, B.longum)-in adults experiencing intestinal discomfort.

Conditions

  • Intestinal Discomfort
  • Abdominal Pain/ Discomfort

Interventions

DIETARY_SUPPLEMENT

Berberine

The study foresees the intake of 3 capsules per day during 8 weeks

DIETARY_SUPPLEMENT

Bifidobacterium longum

The study foresees the intake of 3 capsules per day during 8 weeks

DIETARY_SUPPLEMENT

Bifidobacterium longum and Berberine

The study foresees the intake of 3 capsules per day during 8 weeks

DIETARY_SUPPLEMENT

Placebo

The study foresees the intake of 3 capsules per day during 8 weeks

Sponsors & Collaborators

  • Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Louise Deldicque, Pr · Université Catholique de Louvain

  • Sylvie Copine, Dr · Université Catholique de Louvain

  • Laurent Simar, Dr · Université Catholique de Louvain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-16
Primary Completion
2026-10-24
Completion
2026-12-24

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07420231 on ClinicalTrials.gov